Background: Immature platelet fraction (IPF, %) is a measure of reticulated platelets (RPs), which represents the state of thrombopoiesis. The IPF is obtained from an automated hematology analyzer as one of the platelet parameters. This study was performed to establish reference intervals of IPF and its cut-off values for the differential diagnosis of thrombocytopenia.
INTRODUCTION
Thrombocytopenia is a common hematological abnormality that is sometimes associated with severe bleeding [1] . There are many causes for thrombocytopenia, which makes the differential diagnosis of the underlying causes of thrombocytopenia difficult and troublesome. Thrombocytopenia can be caused by enhanced peripheral destruction of platelets as in idiopathic thrombocytopenic purpura/immune thrombocytopenia (ITP) or thrombotic thrombocytopenic purpura. ITP is an acquired immunemediated disease in adults and children characterized by a transient or persistent decrease in the platelet count [2] . According to the American Society of Hematology (1996) , the diagnosis of ITP can be made on the basis of a thorough history and physical examination and a complete blood cell count, including the examination of a peripheral blood smear [3] . A number of studies support the idea that it is not necessary to routinely perform bone marrow examination for the diagnosis of ITP [4] .
Another cause of thrombocytopenia is a decreased production of platelets in the bone marrow as in aplastic anemia (AA) and post-chemotherapy. An accurate platelet count provides only limited information on the likelihood of bleeding in the thrombocytopenic patient [5] . A rapid assessment of platelet production would distinguish between thrombocytopenia due to bone marrow failure, where bleeding is more likely to occur, and thrombocytopenia due to increased peripheral platelet destruction, where bleeding is less common [6] .
During the last 2 decades, automated blood cell coun- [7] .
Reticulated platelets (RPs) are newly formed platelets with higher granule content and a residual amount of megakaryocyte-derived mRNA [8] . The number of RPs is related to thrombopoiesis, which increases with increased production of RPs and decreases when RP production declines [7] . The existence of this relationship offers the possibility to determine whether thrombocytopenia is due to bone marrow failure or increased peripheral destruction, thereby avoiding the need for bone marrow examination [9] . Patients with ITP usually have increased levels of megakaryocytes in the bone marrow, but those with AA or post-chemotherapy have hypoplastic bone marrow [10] .
RPs can be quantified by using flow cytometers and fluorescent dyes such as thiazole orange, which can bind RNA [11] . However, the flow cytometric measurement of RPs has limited clinical use because of much variation in the published reference intervals and lack of standardization [12] . Recently, a new automated measurement of RPs as IPF has been developed within the Sysmex XE-2100 (Sysmex, Kobe, Japan). In this study, we measured the IPF in healthy individuals and patients with ITP and AA to establish appropriate reference intervals and cutoff values of IPF that can be utilized for determining the underlying causes of thrombocytopenia.
MATERIALS AND METHODS

Study subjects
A total of 2,039 healthy individuals (1,161 males and 878 females; median age, 50 yr; range, 0-87 yr) with normal blood count parameters, including normal platelet counts (150-450×10 9 /L), were enrolled in the study to establish reference intervals for IPF% in the healthy population ( Table 1 ).
The diagnoses of the patient groups included ITP (N=150) and AA (N=51) with platelet counts of less than 100×10 
Measurement of IPF
The Sysmex XE-2100 (Sysmex) is a fully-automated hematology analyzer employing flow cytometry and a semi-conductor diode laser system to analyze leukocytes, nucleated red cells, and reticulocytes (RET channel) [13] . In the RET channel, 2 fluorescent dyes (polyme- 
Establishment of reference intervals
The reference interval was determined according to the guideline of CLSI [13] . A normality test was performed in all subgroups using the Kolmogorov-Smirnov test. Then, 
Statistical analysis
Statistical analysis was performed using Statistical Analysis Software (SAS) (version 9.1.3; SAS Institute
Inc., Cary, NC, USA). The differences between 2 groups 
RESULTS
Analytical performance of IPF on reproducibility and stability
The reproducibility of the method of duplicate analysis using 40 samples from the control group was good ( Table   2 ). 
Reference intervals of IPF by gender
The median platelet count in 2,039 healthy controls 
IPF in patients with thrombocytopenia
The IPF% (median, range) was significantly higher in patients with ITP (7.7%, 1.0-33.8%) than in healthy indi- Table 3 . Reference interval of IPF (%), P<0.0001 ficity (Fig. 4 ). An IPF% value of 2.6% was the optimal cut-off value for distinguishing healthy controls and ITP patients with a sensitivity of 93.3% and a specificity of 93.9%. The optimal cut-off value for differentiating ITP patients from AA patients was 7.3% with a sensitivity of 54.0% and a specificity of 92.2%. (2) Fig. 4 . The receiver-operating characteristics curves to distinguish the immune thrombocytopenia (ITP) patient group (N=150) from the healthy controls (N=2,039) and aplastic anemia (AA) patient group (N=51). The cut-off value of the immature platelet fraction (2.6%) differentiating ITP from healthy controls is indicated as a circle with a sensitivity of 93.3% and a specificity of 93.9%. The cut-off value for ITP against AA is 7.3% with a sensitivity of 54.0% and a specificity of 92.2%. 
I-Specificity
DISCUSSION
A number of clinical papers on RP analysis have been published over the last decade. These clearly showed that, under conditions of thrombocytopenia, the platelet RNA content correlated directly with megakaryocytic activity [9] . The parameters of platelet production and turnover rate have also been studied using platelet lifespan [14] , glycocalicin index [15] , and thrombopoietin level [16] . However, the platelet lifespan is not widely used because of problems associated with the manipulation of platelets and the use of radioactivity [17] . The glycocalicin index (glycocalicin level normalized for the individual platelet count) is an indicator of platelet turnover, but falsely elevated results have been reported in AA and hypoplastic anemia [18] and very large ranges were observed in autoimmune thrombocytopenic purpura [19] . A thrombopoietin assay is useful for assessing platelet kinetics.
However, all of these assays have generally been limited to research units and are not readily available for monitoring routine clinical samples [9] .
The measurement of RPs by flow cytometry is currently imprecise, expensive, and time-consuming, and it requires considerable expertise and lacks adequate quality control [9] . High variation can be found in the published reference intervals in healthy subjects regarding RPs using different flow cytometric methods and even between laboratories using the same methodology [20] .
The reference range for RPs of healthy individuals, as measured by flow cytometry, has still not been clearly defined [20] , with values quoted from less than 1% [21] to 16.4% [12] .
A newly developed automated measure of IPF is regarded as simple and clinically applicable for the determination of RPs [9] . The previously reported reference interval using the Sysmex XE-2100 for healthy adults is between 0.4% and 10% [1, 9, [22] [23] [24] [25] [26] [27] . The limitations of these reported reference intervals are: 1) small control groups, including less than 150 individuals, 2) incorrect application or lack of application of the CLSI guideline for determining reference intervals, and 3) exclusion of pediatric individuals in the control group.
The CLSI guideline suggests the inclusion of at least 120 subjects of each gender, age, or other subclasses to determine a reference interval for each subgroup [13] . A test for the normal distribution of the data has to be performed, and then, the most suitable mathematical transformation (log, power, etc.) should be applied to the nonparametric reference values to normalize them if it is indicated.
In this study, unlike the previous reports on IPF with small control groups, a large number of healthy individuals (N=2,039) were included as control group to establish the reference interval. The IPF (range of 2.5-97.5%) in healthy controls using the Sysmex XE-2100 was 0.5- The optimal cut-off value for the diagnosis of increased thrombopoiesis was 2.6% with a sensitivity of 93.3% and a specificity of 93.9%, estimated by the ROC curve between controls and ITP patients. Previous studies by Abe et al.
[1], Kim et al. [28] , and Cho et al. [29] reported cut-off values of 7.7%, 2.9%, and 6.1%, respectively. The relatively lower cut-off value obtained in this study (2.6%) might be explained by the lower reference mean value (2.1%) estimated in the present study than in the previous studies (3.3% and 3.4% by Abe et al. [1] and Cho et al. [29] , respectively). Our result is also supported by the report of Kim et al. [28] in which their low mean reference value (1.7%) corresponded with a lower cut-off value (2.9%) similar to this study (2.6%).
However, the optimal cut-off value to differentiate patients with ITP from those with AA was 7.3%, as determined by the ROC curve, with a sensitivity of 54.0% and a specificity of 92.2%. This result may suggest that thrombocytopenic patients with increased IPF% (>7.3%) should not be considered as candidates for bone marrow failure syndrome.
The utility of IPF% other than for the diagnosis of thrombocytopenic patients has been demonstrated in recently published papers. The IPF% can be a useful parameter to estimate platelet recovery after peripheral blood stem cell transplant and chemotherapy, thereby reducing the number of unnecessary platelet transfusions. Following peripheral blood stem cell transplant in adults, the IPF% value rises 1-2 days prior to the increment in platelet count [23, 25] . Saigo et al. [30] observed platelet recovery within 3-7 days after the day of peak IPF% in pediatric patients with various malignant disorders after chemotherapy.
In conclusion, this is the first report on the reference interval of IPF% in a large-scale study including more than 2,000 healthy individuals. This reference interval can be utilized as a basis for forthcoming studies on platelet transfusions, transplantations, and hematologic recovery after chemotherapy in various malignant diseases, which have been actively studied in clinical investigations.
